Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals.

Conventional identification (CI) of yeasts is based on morphological, biochemical and/or immunological methods. Matrix-assisted laser desorption/ionization - time of flight (MALDI-TOF or MT-MS) mass spectrometry has been proposed as a new method for the identification of microorganisms. This prospective study compared the performance of MT-MS and CI for the identification of yeasts isolated from clinical samples. Sequencing of the internal transcribed spacer (ITS) regions of ribosomal DNA was used as the reference method in the analysis of a total of 1207 yeast isolates. Concordance between MT-MS and CI was observed for 1105 isolates (91.5%), while 74 isolates (6.1%) were misidentified. Molecular identification revealed that 73 of these 74 isolates were identified correctly by MT-MS and CI correctly identified the last one. Concordance between the two techniques was excellent for the medically-important species (98-100%), including the identification of closely-related species (Candida albicans/C. dubliniensis; C. inconspicua/C. norvegensis; C. parapsilosis/C. metapsilosis/C. orthopsilosis). Only 2.3% of isolates belonging to C. famata, C. lambica and C. magnoliae or to Geotrichum spp. and Trichosporon spp. were not identified by MT-MS. This investigation highlights the potential of MT-MS-based yeast identification as a reliable, time and cost-efficient alternative to CI.

[1]  C. D. Garner,et al.  Molecular Identification of Veterinary Yeast Isolates by Use of Sequence-Based Analysis of the D1/D2 Region of the Large Ribosomal Subunit , 2010, Journal of Clinical Microbiology.

[2]  Samuel A. Lee,et al.  Emerging opportunistic yeast infections. , 2011, The Lancet. Infectious diseases.

[3]  P. Elsner,et al.  Identification of yeast isolated from dermatological patients by MALDI‐TOF mass spectrometry , 2012, Mycoses.

[4]  Gilbert GREUB,et al.  Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. , 2012, FEMS microbiology reviews.

[5]  L. Pagano,et al.  Invasive Infections Caused by Trichosporon Species and Geotrichum capitatum in Patients with Hematological Malignancies: a Retrospective Multicenter Study from Italy and Review of the Literature , 2005, Journal of Clinical Microbiology.

[6]  V. Ranieri,et al.  Invasive candidiasis and candidemia: new guidelines. , 2009, Minerva anestesiologica.

[7]  K. Marr,et al.  Emerging fungal diseases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  T. Maier,et al.  Novel, improved sample preparation for rapid, direct identification from positive blood cultures using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. , 2011, The Journal of molecular diagnostics : JMD.

[9]  G. Allmaier,et al.  Evaluation of matrix-assisted laser desorption/ionization (MALDI) preparation techniques for surface characterization of intact Fusarium spores by MALDI linear time-of-flight mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.

[10]  M. Kawano,et al.  Catheter-Related Fungemia Due to Fluconazole-Resistant Candida nivariensis , 2007, Journal of Clinical Microbiology.

[11]  P. D. Rogers,et al.  Proteomic analysis of experimentally induced azole resistance in Candida glabrata. , 2006, The Journal of antimicrobial chemotherapy.

[12]  D. Beezhold,et al.  Discrimination of Aspergillus isolates at the species and strain level by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting. , 2008, Analytical biochemistry.

[13]  A. Espinel-Ingroff.  In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. , 2003, Revista iberoamericana de micologia.

[14]  J. Bishop,et al.  Identification of Candida nivariensis and Candida bracarensis in a Large Global Collection of Candida glabrata Isolates: Comparison to the Literature , 2009, Journal of Clinical Microbiology.

[15]  R. Kuykendall,et al.  Nucleotide sequence analysis of the 5·8S rDNA and adjacent ITS2 region of Candida albicans and related species , 1993, Yeast.

[16]  G Greub,et al.  Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Bacterial Strains Routinely Isolated in a Clinical Microbiology Laboratory , 2010, Journal of Clinical Microbiology.

[17]  M. Pfaller,et al.  Epidemiology of Invasive Mycoses in North America , 2010, Critical reviews in microbiology.

[18]  A. Thiébaut,et al.  European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update , 2011, Bone Marrow Transplantation.

[19]  L. Hall,et al.  Performance and Cost Analysis of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Routine Identification of Yeast , 2011, Journal of Clinical Microbiology.

[20]  C. Gaillardin,et al.  Molecular identification of closely related Candida species using two ribosomal intergenic spacer fingerprinting methods. , 2011, The Journal of molecular diagnostics : JMD.

[21]  D. Kontoyiannis,et al.  Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. , 2008, Medical mycology.

[22]  E. Claas,et al.  High-Throughput Identification of Bacteria and Yeast by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Conventional Medical Microbiology Laboratories , 2010, Journal of Clinical Microbiology.

[23]  J. Golmard,et al.  Rapid Species Diagnosis for Invasive Candidiasis Using Mass Spectrometry , 2010, PloS one.

[24]  T. C. White,et al.  Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. , 2000, The Journal of infectious diseases.

[25]  S. V. van Hal,et al.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Identification of Yeasts Is Contingent on Robust Reference Spectra , 2011, PloS one.

[26]  P. Murray,et al.  Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Clinically Important Yeast Species , 2010, Journal of Clinical Microbiology.

[27]  J. Mandrekar,et al.  Dermatophyte Identification Using Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry , 2011, Journal of Clinical Microbiology.

[28]  P. Berche,et al.  Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  D. Marriott,et al.  Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[30]  Chong-Jen Yu,et al.  Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes. , 2009, International journal of antimicrobial agents.

[31]  A. Hoerauf,et al.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Fast and Reliable Identification of Clinical Yeast Isolates , 2009, Journal of Clinical Microbiology.

[32]  R. Cole,et al.  MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers , 2008, Analytical and bioanalytical chemistry.

[33]  M. Ziemer,et al.  The use of ITS DNA sequence analysis and MALDI‐TOF mass spectrometry in diagnosing an infection with Fusarium proliferatum , 2008, Experimental dermatology.

[34]  J. Sobel,et al.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  S. Orenga,et al.  Yeast identification--past, present, and future methods. , 2007, Medical mycology.

[36]  C. Linton,et al.  Candida nivariensis, an Emerging Pathogenic Fungus with Multidrug Resistance to Antifungal Agents , 2008, Journal of Clinical Microbiology.

[37]  D. Coleman,et al.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. , 1995, Microbiology.

[38]  T. Walsh,et al.  Uncommon opportunistic fungi: new nosocomial threats. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[39]  Christophe Hennequin,et al.  MALDI‐TOF MS‐based drug susceptibility testing of pathogens: The example of Candida albicans and fluconazole , 2009, Proteomics.

[40]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[41]  M. Cuenca‐Estrella,et al.  Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia. , 2011, Medical mycology.

[42]  J. Schrenzel,et al.  Comparative Analysis of PCR–Electrospray Ionization/Mass Spectrometry (MS) and MALDI-TOF/MS for the Identification of Bacteria and Yeast from Positive Blood Culture Bottles , 2011, Clinical chemistry.

[43]  Hsien-Chang Chang,et al.  Identification of Medically Important Yeast Species by Sequence Analysis of the Internal Transcribed Spacer Regions , 2006, Journal of Clinical Microbiology.

[44]  M. Kuhns,et al.  Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[45]  A. Urbani,et al.  MALDI-TOF mass spectrometry proteomic phenotyping of clinically relevant fungi. , 2011, Molecular bioSystems.

[46]  T. de Baère,et al.  Validation of a modified algorithm for the identification of yeast isolates using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[47]  R. Courcol,et al.  Evaluation of VITEK 2 colorimetric cards versus fluorimetric cards for identification of yeasts. , 2006, Diagnostic microbiology and infectious disease.

[48]  K. Marr.  The changing spectrum of candidemia in oncology patients: therapeutic implications , 2000, Current opinion in infectious diseases.